MTD's fourth-quarter 2024 results reflect strong growth in the Laboratory business. However, softness in the Food Retail business reflects weaker demand.
Mettler-Toledo (MTD) came out with quarterly earnings of $12.41 per share, beating the Zacks Consensus Estimate of $11.69 per share. This compares to earnings of $9.40 per share a year ago.
Medical equipment maker Mettler-Toledo International forecast annual profit above estimates on Thursday, banking on strong demand for its laboratory instruments used in drug development.
Beyond analysts' top -and-bottom-line estimates for Mettler-Toledo (MTD), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2024.
Mettler-Toledo International is an interesting company, but not one that comes attractively priced. Due to mixed financial results, MTD is now even more expensive, prompting a downgrade to 'sell'. Revenue and profit inconsistencies, especially in China, and high operating costs overshadow minor improvements in gross profit margins.
Mettler-Toledo's Q3 sales were up 1% year-over-year and behind expectations. Management projects 2025 sales growth of 3% and my numbers get to ~$1 billion in NOPAT by this year. China and ex-US sales have been a drag on performance and this must be considered going forward.
MTD Q3 2024 results reflect strong growth in the Laboratory business. However, softness in the Food Retail and Industrial business reflects weaker demand.
Mettler-Toledo International Inc. (NYSE:MTD ) Q3 2024 Earnings Conference Call November 8, 2024 8:30 AM ET Company Participants Adam Uhlman - Head of Investor Relations Patrick Kaltenbach - Chief Executive Officer Shawn Vadala - Chief Financial Officer Conference Call Participants Vijay Kumar - Evercore ISI Matt Sykes - Goldman Sachs Dan Arias - Stifel Dan Leonard - UBS Jack Meehan - Nephron Research Rachel Vatnsdal - JPMorgan Josh Waldman - Cleveland Research Patrick Donnelly - Citi Tycho Peterson - Jefferies Michael Ryskin - Bank of America Operator Hello and welcome to the Mettler-Toledo Third Quarter 2024 Earnings Call. All lines have been placed on mute to prevent any background noise.
Mettler-Toledo (MTD) came out with quarterly earnings of $10.21 per share, beating the Zacks Consensus Estimate of $10 per share. This compares to earnings of $9.80 per share a year ago.
Medical equipment maker Mettler-Toledo International beat third-quarter profit estimates on Thursday, helped by increased demand for its laboratory instruments used in drug development and research.
Get a deeper insight into the potential performance of Mettler-Toledo (MTD) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Mettler-Toledo (MTD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.